Torque launches with $25 million in funding to arm immune cells – Chemical & Engineering News
Chemical & Engineering News |
Torque launches with $25 million in funding to arm immune cells
Chemical & Engineering News Torque joins a legion of companies tinkering with immune cells so they can find and attack cancer cells. In August, the U.S. Food & Drug Administration approved the first chimeric antigen receptor (CAR) T-cell therapy, Novartis' Kymriah, to treat kids … Torque takes tumor tech out of stealth with $25M backing, new CEO Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell … |
